Psoriatic Arthritis Biologic Naïve

  • Male or female subjects who are 18-75 years of age
  • Must have a history consistent with PsA ≥6 months at Screening
  • Must have a documented history or active signs of at least one of the following at Screening: Plaque psoriasis or nail changes attributed to psoriasis
  • Have had inadequate response or intolerance to ≥1 csDMARD, apremilast and / or NSAID, administered over the course of ≥12 weeks for the treatment of PsA
  • Cannot have Prior exposure to a JAK inhibitor >2 doses